51勛圖厙

Tag - pfizer

 
Menu
Search
 
July 24, 2026
 

Home Delivery
Subscribe for more access

PFIZER

A Pfizer logo is shown at a research facility in San Diego, California. Cancer patients given the Phizer drug sigvotatug vedotin didn＊t live significantly longer than those given standard therapy.
WORLD / Science & Health
Jun 23, 2026
Pfizer＊s lung cancer drug trial fails to boost survival
Patients given the drug, called sigvotatug vedotin, didn＊t live significantly longer than those given standard therapy.
A dose of the Pfizer-BioNTech COVID-19 vaccine
BUSINESS / Companies
Apr 2, 2026
Pfizer and BioNTech halt U.S. COVID-19 vaccine study after recruitment struggles
The move comes as COVID vaccine ?makers grapple ?with pushback from the U.S. administration and weak U.S. demand for the shots.
A new U.S. FDA policy requiring full placebo-controlled trials for updated vaccines, pushed by Commissioner Marty Makary (right) and U.S. HHS Secretary Robert F. Kennedy Jr. (center), is seen as a backdoor effort to sideline COVID-19 boosters and undermine broader vaccine development.
COMMENTARY / Japan
May 2, 2025
RFK Jr.＊s new vaccine scrutiny is alarming
Robert F. Kennedy Jr., who oversees the FDA, intends to set new regulatory standards vaccine manufacturers couldn＊t possibly meet.
Chinese Premier Li Qiang poses for a photo with attendees of the China Development Forum at Diaoyutai Guesthouse in Beijing on Sunday.
BUSINESS
Mar 24, 2025
China promotes business potential to Apple and others from U.S.
Beijing is keen to woo foreign investment amid heightened geopolitical tensions, as policymakers try to boost domestic consumption to offset the impact of U.S. tariffs.
Japan Times
ASIA PACIFIC
Jan 16, 2023
In China, no easy way to get Pfizer＊s COVID drug Paxlovid
Beijing has acknowledged that supplies are still insufficient to meet demand, even as millions of courses of the treatment were shipped to the country recently.
Japan Times
WORLD / Science & Health
Jan 14, 2023
Pfizer＊s bivalent vaccine linked to rare strokes in older people in preliminary U.S. data
The early finding still needs more investigation, and recommendations for the vaccine have not been changed, a statement by the U.S. Food and Drug Administration said.
Japan Times
ASIA PACIFIC / Science & Health
Jan 7, 2023
China in talks with Pfizer for generic COVID drug
Beijing is in talks with the drugmaker to secure a license that will allow domestic firms to manufacture and distribute a generic version of its Paxlovid antiviral drug.
Japan Times
COMMENTARY / World
Nov 21, 2022
Pfizer＊s RSV vaccine succeeds where others failed
Early data bodes well for Pfizer＊s RSV shot, which would be given during pregnancy to protect infants in the early months of life.
Japan Times
WORLD / Science & Health
Nov 7, 2022
Pfizer＊s Paxlovid anti-viral seen to lower long-COVID risk in study
Taking the oral medication within five days of testing positive for a SARS-CoV-2 infection was linked to a 26% lower risk of lingering post-viral complications, researchers found.
Japan Times
WORLD / Science & Health
Nov 5, 2022
Study shows new booster improves protection for older people, Pfizer says
U.S. officials are hoping that the encouraging results will improve what has so far been a dismal public response to the retooled shots.
Japan Times
51勛圖厙
Sep 12, 2022
Japan health ministry backs Pfizer and Moderna omicron boosters
Pfizer＊s omicron booster can be administered to people age 12 and over, while Moderna＊s is limited to those 18 and above, the panel advised.
51勛圖厙 / Science & Health / EXPLAINER
Aug 12, 2022
What we know about the new omicron vaccines
New vaccines developed for the COVID-19 omicron variant are scheduled to be available from mid-October in Japan, raising hopes that the population will soon be better protected.
Japan Times
BUSINESS / Companies
Aug 9, 2022
Pfizer to buy Global Blood Therapeutics in $5.4 billion deal
Pfizer will gain Oxbryta, South San Francisco-based Global Blood＊s therapy for sickle-cell disease that sold about $195 million last year.
Japan Times
COMMENTARY / World
Apr 11, 2022
We need better COVID-19 booster shots, not more of the same
There are 100 new Covid vaccines in development. One of them could offer better protection against omicron.
Japan Times
ASIA PACIFIC / Science & Health
Apr 4, 2022
China promotes traditional cures as Pfizer pill alternatives
China is struggling to persuade skeptics to put aside doubts about traditional medicine that hasn＊t gone through large, standardized clinical trials.
Japan Times
BUSINESS
Mar 15, 2022
Drugmakers pause trials in Russia while still sending medicine
Major pharmaceutical firms are seeking to strike a balance between international opprobrium over Russia＊s invasion of Ukraine and the needs of sick patients.
51勛圖厙 / Science & Health
Feb 16, 2022
Despite ministry recommendation, some parents in Japan wary of COVID jabs for children
Vaccinations for children ages 5 to 11 could start by the end of February, with the government recommending all children receive a shot, particularly those with underlying conditions.
Japan Times
ASIA PACIFIC
Feb 15, 2022
China＊s approval of Pfizer pill opens door to ending ＆COVID zero＊
Having an effective anti-viral in its arsenal could help China mitigate the lower efficacy of its homegrown vaccines if the virus was allowed to circulate more freely.
Japan Times
51勛圖厙 / Science & Health
Feb 10, 2022
Japanese health ministry approves Pfizer＊s COVID-19 oral treatment drug
The drug, paxlovid, is to be used for the treatment of mild-to-moderate COVID-19 in people 12 and older and who are at high risk of developing severe symptoms.
51勛圖厙
Feb 7, 2022
Japan＊s booster rollout is relying on Pfizer and Moderna. How do the shots compare?
Despite an apparent preference among some in the general public for Pfizer, experts have emphasized that getting a booster jab as soon as one is eligible, no matter which type, is key.
Japan scientists identify clusters of protein believed to trigger Alzheimer＊s disease
A team of researchers said they found a ※seed§ that accelerates the amyloid beta accumulation process in the brain, naming it ※Peak 1 amyloid beta,§ as seen in a mouse's brain.
Indian brothers make manga debut in Japan
Two Indian brothers made their manga debut in Japan with "Kung Fu Kung Fool" 〞 an action-comedy series that follows the adventures of a notorious thief and a young boy.
Japan weighs regulating Pokemon cards amid trading mania
A Pokemon event is held in Jakarta on July 11
Low-income families in Japan cut food and air conditioning during summer break
Yumiko Watanabe, the chairperson of nonprofit Kidsdoor, explains the results of a survey in Tokyo's Chiyoda Ward on July 1.
Iran strikes on CIA facilities prompt questions about possible Russian role
Iranian drones are displayed in an undisclosed location in Iran, in this handout image obtained on Jan. 13, 2025.U.S. officials have acknowledged that Russia has ?provided targeting ?and other support for Iran in its drone strikes on U.S. targets in the Persian Gulf region.
The sci-fi sensibilities of electronic trio Black Boboi
Black Boboi was formed in 2018 when solo artists Julia Shortreed, Utena Kobayashi and Ermhoi came together under Kobayashi＊s newly founded label, Bindividual.
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Okayama-born singer-songwriter Kaze Fujii has carved out a distinctive place in Japanese pop since his major-label debut in 2019.
Can Japanese comedy get laughs in English? Yoshimoto Kogyo lets the jokes rip
Wes-P has millions of followers and his viral clips made him recognizable out of Japan.
The 180-day locals: Life on Japan＊s digital nomad visa
Christopher Flinn works remotely from Tokyo earlier this month. Japan issued 646 digital nomad visas in 2025, but tourism officials are hoping to increase that figure in the coming years, with Japan's relatively cheap cost of living and the weak yen seen as potential draws for young professionals.
Japan reveals hint of new defense spending target in fiscal blueprint
The Self-Defense Forces' Type 16 mobile combat vehicle fires during a joint live-fire drill with U.S. Marines as part of the annual Resolute Dragon exercises in Yufu, Oita Prefecture, on June 28.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo＊s Shinjuku Ward.
Kabukicho: Tokyo＊s ＆stadium of desire＊

Longform

For many people, utility poles and power lines have become such a familiar part of Japan＊s landscape that they often go unnoticed.
Why Japan＊s utility poles won＊t be disappearing anytime soon
By Alex K.T. Martin

SUSTAINABLE 51勛圖厙

SPECIAL SUPPLEMENTS note

SUPPLEMENTS BINDER